Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
1.
Lung ; 199(4): 395-402, 2021 08.
Article in English | MEDLINE | ID: mdl-34387726

ABSTRACT

PURPOSE: Preoperative pulmonary function testing is mandatory for non-small cell lung cancer (NSCLC) surgery. The predicted postoperative FEV1 (ppoFEV1) is used for further risk stratification. We compared the ppoFEV1 with the postoperative FEV1 (postFEV1) in order to improve the calculation of the ppoFEV1. METHODS: 87 patients voluntarily received an FEV1 assessment 1 year after surgery. ppoFEV1 was calculated according to the Brunelli calculation. Baseline characteristics and surgical procedure were compared in a uni- and multivariate analysis between different accuracy levels of the ppoFEV1. Parameters which remained significant in the multinominal regression analysis were evaluated for a modification of the ppoFEV1 calculation. RESULTS: Independent factors for a more inaccurate ppoFEV1 were preoperative active smoking (odds ratio (OR) 4.1, confidence interval (CI) 3.6-6.41; p = 0.01), packyears (OR 4.1, CI 3.6-6.41; p = 0.008), younger age (OR 1.1, CI 1.01-1.12; p = 0.03), and patients undergoing pneumectomy (OR 5.55, CI 1.35-23.6; p = 0.01). For the customized ppoFEV1 we excluded pneumonectomies. For patients < 60 years, an additional lung segment was added to the calculation. ppoFEV1 = preFEV1 × [Formula: see text]. For actively smoking patients with more than 30 packyears we subtracted one lung segment from the calculation ppoFEV1 = PreFEV1 × [Formula: see text]. CONCLUSION: We were able to enhance the predictability of the ppoFEV1 with modifications. The modified ppoFEV1 (1.828 l ± 0.479 l) closely approximates the postFEV1 of 1.823 l ± 0.476 l, (0.27%) while the original ppoFEV1 calculation is at 1.78 l ± 0.53 (2.19%). However, if patients require pneumectomy, more complex techniques to determine the ppoFEV1 should be included to stratify risk.


Subject(s)
Carcinoma, Non-Small-Cell Lung , Lung Neoplasms , Carcinoma, Non-Small-Cell Lung/surgery , Forced Expiratory Volume , Humans , Lung/surgery , Lung Neoplasms/surgery , Pneumonectomy
2.
Pneumologie ; 75(3): 187-190, 2021 Mar.
Article in German | MEDLINE | ID: mdl-33307556

ABSTRACT

The SARS-CoV-19 pandemic continues to be globally related with significant morbidity and mortality, making protective measures to prevent transmission of the virus still necessary. Healthcare employees are exposed to a higher risk of infection and this is particularly true when performing aerosol-generating procedures such as bronchoscopy.Since the publication of recommendations for performing a bronchoscopy in the times of COVID-19 more than six months ago, the risk situation has not changed significantly, but due to the considerable gain in knowledge in the meantime, an update of the recommendations was necessary.The updated recommendations include the reduction of aerosol formation, the personal protection of the people involved in the procedure, as well as measures to better organize the processes in the endoscopy suite in order to perform bronchoscopic procedures securely even in times of COVID-19.


Subject(s)
COVID-19 , Pandemics , Bronchoscopy , Health Personnel , Humans , SARS-CoV-2
3.
Sleep Breath ; 24(3): 825-833, 2020 Sep.
Article in English | MEDLINE | ID: mdl-31388800

ABSTRACT

PURPOSE: Previous studies revealed substantially varying therapy efficacy of automatic continuous positive airway pressure (APAP) devices in the treatment of obstructive sleep apnea (OSA). We evaluated the efficacy of a new APAP device using the forced oscillation technique (FOT) to evaluate upper airway obstruction during apneas and flow contour analyses during hypopneas. METHODS: Forty-six initially diagnosed OSA patients were included and the pressure range was set from 5 to 20 hPa. Therapy efficacy was assessed based on the reduction of apnea-hypopnea index (AHI), improvement of objective sleep quality parameters, and the appropriateness of the device's pressure regulation. RESULTS: AHI and arousal index significantly decreased during APAP therapy (median [interquartile range]: AHI 36 [23-55] vs. 2 [1-6]/h, arousal index 30 [22-45] vs. 15 [10-19]/h, both p < 0.001). The amount of slow wave sleep (SWS) and rapid-eye-movement (REM) sleep significantly increased (SWS 20 [14-29] vs. 29 [19-34]%, REM 16 [11-21] vs. 24 [14-30]%, both p < 0.01). Most residual respiratory events during therapy were of central etiology and attributable to five patients, who presented with treatment-emergent central sleep apnea. The device's pressure regulation abolished most obstructive respiratory events (n = 6.7 residual obstructive events per patient). Of central respiratory events, 534/646 (83%) did not lead to pressure increases. CONCLUSION: This pilot study provides a proof of concept that the APAP device combining FOT and evaluation of flow contour allows for the suppression of obstructive events without relevant false reactions.


Subject(s)
Continuous Positive Airway Pressure/methods , Oscillometry/methods , Positive-Pressure Respiration/methods , Sleep Apnea, Obstructive/therapy , Adult , Female , Follow-Up Studies , Forced Expiratory Volume/physiology , Humans , Male , Middle Aged , Pilot Projects , Respiratory Function Tests
4.
Pneumologie ; 73(4): 219-224, 2019 Apr.
Article in German | MEDLINE | ID: mdl-30895592

ABSTRACT

BACKGROUND: Evaluating the focus of treatment in pneumological inpatient and outpatient care is of special interest due to its impact on physician, patient and research. This work describes differences and commonalities in the focus of treatment of current pneumological inpatient and outpatient care and discusses their impact on patient, physician and research. METHODS: This study compares the inpatient and outpatient sector based on the prevalence of ICD codes of a pneumological specialist clinic (5.211 cases of 2016) and the most prevalent ICD-10 codes of pneumology practices in the third quarter 2016, published by the Association of Statutory Health Insurance Physicians North Rhine ("Kassenärztliche Vereinigung Nordrhein", 142.431 cases). RESULTS: Whereas the proportion of many pneumological disease patterns treated in physicians' practices and hospitals is similar, the relative frequencies of specific diseases differ considerably between the two. Treatment of allergic conditions such as allergic rhinopathy and bronchial asthma is mostly done on an outpatient basis while respiratory insufficiency and lung carcinoma constitute domains of pneumological inpatient care. CONCLUSION: Despite many commonalities in the focus of treatment in pneumological inpatient and outpatient care, there are also substantial differences between the two. These affect medical training, the conduct of clinical studies, and in particular, patient care. In order to maintain a high level of medical care in all areas of pneumology a close exchange between inpatient and outpatient sector seems crucial. In the end, the availability of medical expertise across both sectors will benefit all: physicians, patients and medical science.


Subject(s)
Inpatients/statistics & numerical data , Outpatients/statistics & numerical data , Pulmonary Medicine , Respiratory Tract Diseases/epidemiology , Ambulatory Care , Diagnosis-Related Groups , Hospitalization , Humans , Prevalence , Respiratory Tract Diseases/classification
5.
Pneumologie ; 72(7): 523-530, 2018 Jul.
Article in German | MEDLINE | ID: mdl-29788515

ABSTRACT

AIM OF THE STUDY: Survey of specialist pulmonary medicine health care structures for patients with interstitial lung disease (ILD) in Nordrhein-Westfalen, Germany. METHODS: The Western German Respiratory Society initiated a voluntary registration of ILD expert centers. Structural quality and processes were evaluated by questionnaire. RESULTS: 49 centers were registered, 46 allowed analysis of their center data (15 pulmonology specialist practices, 34 hospital pulmonology departments). Specialist practices saw a median of 360 ILD patients per year (26 % first diagnosis), hospital departments a median of 105 ILD patients per year (63 % first diagnosis). 10 centers diagnose more than 100 new ILD cases per year. Specialist practices report median 50 bronchoscopies per year, hospital departments median 1396. 78 % of the centers participate in a multidisciplinary ILD case conference. CONCLUSION: Several ILD expert centers were identified in Nordrhein-Westfalen. Outpatient care mainly involves the monitoring of ILD patients, inpatient services focus on complex initial diagnostics or cases with unusual disease behaviour. ILD centers meeting regional health care needs should be supported in their development.


Subject(s)
Delivery of Health Care/organization & administration , Lung Diseases, Interstitial , Pulmonary Medicine/standards , Germany , Humans , Lung Diseases, Interstitial/diagnosis , Lung Diseases, Interstitial/therapy , Pilot Projects , Societies, Medical , Surveys and Questionnaires
6.
Pneumologie ; 67(4): 228-32, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23479399

ABSTRACT

PURPOSE: Both the parallel use of intensive care unit (ICU)-ventilators and ventilators dedicated to non-invasive ventilation (NIV), as well as the construction of some expiratory valves in single circuit breathing tubes may lead to misconnections which are potentially fatal for the patient. METHODS: We demonstrate first a case of a misconnected expiratory valve in a patient with invasive home ventilation. In a second case, the mistaken connection of a non-invasive ventilator to an endotracheal tube leading to carbon dioxide (CO2)-rebreathing is demonstrated. A third case describes a patient with home non-invasive ventilation who had been delivered a non-vented mask out-of-hospital, likewise leading to CO2-rebreathing. CONCLUSION: Human error is the main reason for critical incidents in medicine and the most serious unintended events often involve mechanical ventilation. A regular instruction of medical staff and patients is necessary. The demonstrated misconnections are examples of latent errors "waiting to happen". To prevent these errors from being made in the future, technological solutions similar to the aviation effort to improve safety are needed.


Subject(s)
Equipment Failure , Home Care Services , Medical Errors/prevention & control , Noninvasive Ventilation/adverse effects , Respiration, Artificial/adverse effects , Respiratory Insufficiency/etiology , Respiratory Insufficiency/prevention & control , Aged , Female , Humans , Male , Noninvasive Ventilation/instrumentation , Respiration, Artificial/instrumentation
7.
Sarcoidosis Vasc Diffuse Lung Dis ; 30 Suppl 1: 48-51, 2013 Sep 01.
Article in English | MEDLINE | ID: mdl-24081246

ABSTRACT

Idiopathic pulmonary fibrosis (IPF), the most common subtype of idiopathic interstitial pneumonia, is a chronic progressive lung disease with a very high mortality. Usually diagnosis is established in adults older than 50 years and most cases are considered to be sporadic. Individuals with a familial form of IPF have at least one affected member in the same primary biological family and account for less than 5% of total patients. Sporadic and familial IPF are clinically and histologically indistinguishable from one another, although some familial forms appear to develop at an earlier age and exhibit different patterns of gene transcription. This case study describes the early clinical course of a patient diagnosed with a familial form of IPF.


Subject(s)
Idiopathic Pulmonary Fibrosis , Pulmonary Fibrosis , Chronic Disease , Humans , Idiopathic Interstitial Pneumonias , Pulmonary Fibrosis/diagnosis
9.
Clin Chem ; 46(5): 631-5, 2000 May.
Article in English | MEDLINE | ID: mdl-10794744

ABSTRACT

BACKGROUND: The LightCycler(TM) combines rapid amplification of nucleic acids in glass capillaries with melting curve analysis based on fluorescence resonance energy transfer for the sensitive detection of point mutations in various settings, such as drug resistance and hereditary diseases. Point mutations leading to an altered structure of lanosteroldemethylase, the target enzyme of the fungistatic azoles, are an important mechanism of acquired resistance in Candida albicans. METHODS: We screened 13 fluconazole-resistant C. albicans and 21 fluconazole-resistant C. tropicalis strains (minimum inhibitory concentration >128 mg/L), isolated from patients with AIDS, for the presence of defined point mutations by comparing conventional cycle sequencing with a newly designed LightCycler-based assay. RESULTS: In C. tropicalis, 5 of 21 isolates showed the wild-type sequence, and 8 of 21 showed the homozygous nucleotide exchange thymine to cytosine at position 1554 (T1554C). A heterozygous genotype was detected in 8 of 21 isolates by the LightCycler, but in only 3 of 21 isolates by conventional cycle sequencing. In 2 of 13 C. albicans isolates, a homozygous point mutation leading to an amino acid exchange at position 464 (glycine to serine) was detected in both assays. CONCLUSION: The LightCycler technique offers standardized, fast, sensitive, and reproducible detection of point mutations in different Candida spp.


Subject(s)
Candida/genetics , Point Mutation , Acquired Immunodeficiency Syndrome/microbiology , Antifungal Agents/pharmacology , Candida/isolation & purification , DNA, Fungal/genetics , Electrophoresis, Agar Gel , Fluconazole/pharmacology , Humans , Microbial Sensitivity Tests , Polymerase Chain Reaction , Reproducibility of Results , Sensitivity and Specificity , Spectrometry, Fluorescence
10.
J Clin Microbiol ; 38(2): 586-90, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10655350

ABSTRACT

The Light Cycler technique combines rapid in vitro amplification of DNA in glass capillaries with real-time species determination and quantification of DNA load. We have established a quantitative PCR protocol for two clinically important pathogens, Candida albicans and Aspergillus fumigatus. The sensitivity of the assay was comparable to those of previously described PCR protocols (5 CFU/ml). Specific detection of C. albicans and A. fumigatus could be achieved. The assay showed a high reproducibility of 96 to 99%. The assay was linear in a range between 10(1) and 10(4) Aspergillus conidia. As capillaries do not have to be reopened for post-PCR analysis, the risk of carryover contaminations could be minimized. The Light Cycler allowed quantification of the fungal loads in a limited number of clinical specimens from patients with hematological malignancies and histologically proven invasive fungal infections. Five of nine positive samples had fungal loads between 5 and 10 CFU/ml of blood, two of nine positive samples had fungal loads between 10 and 100 CFU/ml of blood, and two of nine samples had fungal loads of more than 100 CFU/ml of blood. All samples were also found to be PCR positive by PCR-enzyme-linked immunosorbent assay analysis.


Subject(s)
Aspergillosis/diagnosis , Aspergillus fumigatus/isolation & purification , Candida albicans/isolation & purification , Candidiasis/diagnosis , DNA, Fungal/analysis , Polymerase Chain Reaction/methods , Aspergillosis/microbiology , Aspergillus fumigatus/genetics , Candida albicans/genetics , Candidiasis/microbiology , Electrophoresis, Agar Gel , Humans , Reproducibility of Results , Sensitivity and Specificity , Spectrometry, Fluorescence , Thermodynamics
11.
J Clin Microbiol ; 37(4): 1200-2, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10074553

ABSTRACT

Successful in vitro amplification of fungal DNA in clinical specimens has been reported recently. In a collaboration among five European centers, the frequency and risk of contamination due to airborne spore inoculation or carryover contamination in fungal PCR were analyzed. The identities of all contaminants were specified by cycle sequencing and GenBank analysis. Twelve of 150 PCR assays that together included over 2,800 samples were found to be contaminated (3.3% of the negative controls were contaminated during the DNA extraction, and 4.7% of the PCR mixtures were contaminated during the amplification process). Contaminants were specified as Aspergillus fumigatus, Saccharomyces cerevisiae, and Acremonium spp. Further analysis showed that commercially available products like zymolyase powder or 10x PCR buffer may contain fungal DNA. In conclusion, the risk of contamination is not higher in fungal PCR assays than in other diagnostic PCR-based assays if general precautions are taken.


Subject(s)
Fungi/genetics , Polymerase Chain Reaction/methods , Acremonium/genetics , Acremonium/isolation & purification , Air Microbiology , Aspergillus fumigatus/genetics , Aspergillus fumigatus/isolation & purification , Base Sequence , DNA Primers/genetics , DNA, Fungal/genetics , DNA, Fungal/isolation & purification , Drug Contamination , Fungi/isolation & purification , Humans , Indicators and Reagents , Multicenter Studies as Topic , Mycoses/diagnosis , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae/isolation & purification , Spores, Fungal/genetics , Spores, Fungal/isolation & purification
SELECTION OF CITATIONS
SEARCH DETAIL